Asia Pacific Cell Counting Market is Estimated to Expand at a Promising CAGR During Forecast to 2023


Market Overview:
Cell Counting Market is expected to witness positive growth in future as it has wide range of applications in research institutes, hospitals, biotechnology and pharmaceuticals companies and it an important tool in research, drug discovery and biopharmaceutical applications. Increasing prevalence of cancer and rising geriatric population are major driver for the market growth. Furthermore, factors responsible for the growth of the cell counting market in Asia Pacific are rising awareness regarding prevalence of disease such as cancer and other lifestyle diseases and improvement in healthcare facilities. High cost of cell counting instruments may create an obstacle for the market growth.
Asia Pacific Cell Counting Market is expected to grow at a CAGR of 10.5% during forecast period 2017 to 2023.
Key Players for Global Asia Pacific Cell Counting Market:
·         Bio-Rad Laboratories Inc
·         General Electric Company
·         Agilent Technologies
·         PerkinElmer Inc
·         Tecan Trading AG
·         BioTek Instruments
·         Danaher
·         Merck KGaA
·         Thermo Fisher Scientific Inc
Segments for Global Asia Pacific Cell Counting Market:
·         The Asia Pacific Cell Counting Market is segmented on the basis on instruments used for cell counting which are spectrophotometer, cell counter, hemocytometer, flow cytometer, hematology analyzer, microscope and other instruments.
·         On the basis of application of cell counting which includes cell structure study and cell analysis, quality control, cell viability, proliferation, signaling, identification, single cell analysis and other applications.
·         It is also segmented on the basis of its end users which are hospitals, research institutes, pharmaceutical and biotechnology companies, clinical research organizations and other end users.
Regional Analysis for Global Asia Pacific Cell Counting Market:
Asia Pacific Cell Counting Market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia Pacific. Japan is the largest market for cell counting due to an increase in prevalence of cancer and demand for new cell counting techniques.  
China and Japan are major manufacturers of medical devices. In China, factors responsible for the market growth are rising geriatric population with chronic diseases, increasing experimental use of cell counting devices, and availability of low cost diagnostic and treatment options.
Rising number of diagnostic centers, growing emphasis of cell counting for the diagnosis of chronic diseases and overall growth of diagnostic services drive the market in India. Lack of awareness about the available diagnostic services also boost the market growth.
Australia and Republic of Korea show slow growth in cell counting market.

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more